Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-202-3 | CAS number: 79-39-0
Specific investigations: other studies
Administrative data
Link to relevant study record(s)
Description of key information
On screening level there is no concern on relevant endocrine modulating properties of this substance.
Additional information
Screening information on endocrine disrupting properties of this substance is available on in vitro and in silico level.
Methacrylamide was negative/ inactive in all 44 in vitro/ in chemico assays performed by US EPA under the ToxCast/ EDSP21 program (18 on estrogen receptor potential, 14 on androgen receptor potential, 10 on thyroid disrupting potential and two on steroidogenesis disrupting potential; US EPA 2021). Respective QSAR models on estrogen and androgen activity (US EPA 2021) and on estrogen, androgen and thyroid activity (Danish EPA, 2021 – partially overlapping with the U.S. EPA models), respectively, indicate that Methacrylamide is inactive as endocrine disruptor.
Thus, on screening level there is no concern on relevant endocrine modulating properties of this substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
